INTRODUCTION
The conventional eye drops are the most convenient and patient compliant non-invasive route for topical ophthalmic drug delivery. Nasolachrymal drainage, epithelial membrane barriers and non-productive absorption of these ophthalmic preparations can result in poor ocular bioavailability and systemic absorption leading side effects. The limited duration time requires frequently dosing up to 4 times per day for many treatments 1 . The active ingredient can be delivered to the posterior ocular tissue segments by different administrations routes such as intravitreal injections, periocular injections, and systemic administration, but all have limitations. To overcome the ocular drug delivery barriers and improve bioavailability, various conventional and novel drug delivery systems have been developed such as emulsion, ointments, suspensions, aqueous gels, nanomicelles, nanoparticles, liposomes, dendrimers, implants, contact lenses, nanosuspensions, microneedles and in situ thermosensitive gels 2, 3 . Nanotechnology based ocular drug delivery systems such as polymeric nanoparticles have revealed promising results for dose optimization, bioavailability and sustained ocular drug delivery to the posterior ocular tissue segments.
Ultra-performance liquid chromatography (UPLC) is a new category of separation technique based upon well-established principles of liquid chromatograph 4, 5 . UPLC provides the benefit of small injection volumes, shortened run times (<5 min), and reduced solvent usage, making it the more economical method for quantitation 6 . Because of its speed and sensitivity, this technique is gaining considerable attention in recent years for pharmaceutical and biomedical analysis 7, 8 . In this study, UPLC was preferred for determination and quantification.
OLO ( Figure 1 ) with histamine H1 receptor antagonistic action is used in ocular allergy and available on the market as eye drops for many years. OLO inhibits both mast cell degranulation and the release of arachidonic acid metabolites in various types of cells 9, 10, 11 . Therefore, OLO loaded polymeric nanoparticles were prepared as an alternative carrier to achieve the mentioned problems. The main purpose of this study was to describe a new assay for the determination of encapsulated OLO in the polymeric nanoparticle formulations. 
METHODOLOGY

Materials
Olopatadine hydrocloride, methanol and sodium acetate were purchased from Sigma (Steinheim, Germany). Eudragit ® RS 100 was obtained from Degussa Röhm Pharma Polymers (Germany). All other reagents and solvents were of analytical grade and purchased from Sigma (Steinheim, Germany). High purity water was used throughout the experiment and prepared using a Millipore Milli-Q water (France) purification system.
Preparation of Polymeric Nanoparticles
Eudragit ® RS 100 polymeric nanoparticles were prepared using spray-drying method 1 . Briefly, Eudragit ® RS 100 and OLO were dissolved in 100 mL methanol and stirred for 12 hours at room temperature with a magnetic stirrer. Final transparent solution was then spray-dried using a Mini Spray Dryer (B-190, BUCHI Labortechnik AG, Flawil, Switzerland) with an inlet and outlet temperature of 120 °C and 70 °C, respectively. A white dry powder was obtained and kept in coloured vials at room temperature until analysis 12, 13 . Olopatadin hydrocloride-free nanoparticles were also prepared as described above. Compositions of the nanoparticles prepared were given in Table 1 . 
Chromatographic Conditions
As a model of combined pharmaceutical applications, the chromatography analyses of the polymeric nanoparticles were performed using an Agilent 1290 Infinity UPLC system (Germany) equipped with a solvent degasser, quaternary pump, autosampler, column oven and diode array detector. Agilent ChemStation software was used for operation control and data collection. The method was developed using a 2.1x50 mm, 1.8 µm Zorbax Eclipse Plus C 18 column with an isocratic mobile phase consisting methanol, water and buffer solution in different ratios. The column temperature was maintained at 40 °C and UV detection was performed at 246 nm. All prepared solutions were filtered through 0.22 µm membrane filters before injection. Statistics were computed using Microsoft Excel 2010 (Redmond, WA, USA).
Analytical Method Validation
The UPLC method was validated according to the International Conference Harmonization (ICH) guideline 2 with respect to specificity, linearity, accuracy and precision, limit of detection (LOD), limit of quantification (LOQ) and statistically evaluated for OLO quantification 14 .
Linearity
A linear relationship was evaluated across the range of the analytical procedure. The linearity of peak normalization (PN) ratios versus concentrations were evaluated using the calibration curve obtained from 5, 10, 15, 20, 25, 30, 35, 40, 45, 50 µg/mL OLO solutions. Six individual replicates at each concentration were analyzed and PN ratios were calculated using the Equation 1.
PN = peak area / retention time (R t ) Equation 1.
Linear least squares methodology was used for the calculation of regression line. The correlation coefficient (r), coefficient of determination (r 2 ), y-intercept, slope of the regression line, residual sum of squares (RSS) was submitted with a plot of the data.
Accuracy
The accuracy of the method was determined by recovery studies evaluated in 3 concentration levels of 10, 30 and 50 µg/mL. Six individual replicates of each concentration were analyzed. Theoretical known amount and calculated assay amount were evaluated with the percent recovery.
Precision
The analyses were performed on the same day to determine repeatability or intra-day variability and on different days to establish the intermediate precision or inter-day variability. Samples were prepared in 3 concentration levels of 10, 25, 50 µg/mL. Six individual replicate of each concentration were analyzed. The precision of the chromatographic method was reported as mean values, standart deviations (SD) and relative standart deviations (RSD) with confidence intervals.
Specificity
The specificity of the method was verified by comparing the chromatograms obtained from the placebo and OLO samples to show the detection ability of the desired components. Absence of any interference between the measured peaks was demonstrated in the representative chromatograms.
Limit of Detection (LOD) and Limit of Quantification (LOQ)
The calibration curve obtained in linearity was used for the detection limits. The LOD and LOQ were theoretically calculated by Equation 2 and 3. LOD = 3.3 σ/S Equation 2.
LOQ = 10 σ/S Equation 3.
where σ is the standard deviation of y-axis interception values of the calibration curve and S is is the slope of the calibration curve 15 .
Robustness
The capacity of the analytical method was investigated by deliberate variation of the mobile phase composition, flow rate, column temperature and stability of OLO. Sample solutions were evaluated for each variation of the method conditions.
Determination of OLO in Polymeric Nanoparticles
Two different extraction methods were used to assess the encapsulation efficiency of the nanoparticles. 5 mg nanoparticle was weighed and dispersed in 2 mL distilled water for the determination of superficial and free OLO. This suspension was centrifuged at 5000 rpm for 3 minutes and filtered. The same amount of nanoparticles were dissolved in 2 mL methanol for the determination of total OLO. The mixture was vortexed for 1 minute and filtered. The loaded amount of OLO was determined by UPLC analyses of these two samples in triplicate. The measurements were also repeated at 3 rd and 6 th months for stability study. Encapsulation efficiency were calculated using the following Equation 4 
RESULTS AND DISCUSSION
Chromatographic Conditions
Initial runs were carried out on methanol and water in various proportions to determime the appropriate mobile phase. Irregular shaping and tailing of OLO peaks were observed in isocratic mode. Satisfactory regular and symmetrical peaks were obtained by using 0.1 M sodium acetate buffer solution. Studies were carried out on a 2.1x50 mm, 1.8 µm Zorbax Eclipse Plus C18 column with an optimized mobile phase of methanol, water and sodium acetate buffer solution (40:50:10, v/v/v) and the sample injection volume was 0.5 µL.
Independent variables such as oven temperature, flow rate and wavelength were also optimized which could greatly influence the separation procedure. The effect of oven temperature was studied between 20 and 40 °C. The highest OLO peak area and shape/base compliance was achieved at an oven temperature of 40 °C. The UV spectrum of OLO was scanned in the range of 200-400 nm and maximum absorption to accomplish the detection and the quantification of OLO was observed at 246 nm. The role of the flow rate on retention time, elution and peak morphology was tested and mobile phase was found to be most reliable at flow rate of 0.5 mL.min -1 . Under these conditions, OLO showed an acceptable retention time of 1.5 min with a run time of 5 min. Analysis time was 7 min including the re-equilibration time.
Before analysis, the chromatographic column was equilibrated with the mobile phase for 30 minutes prior to injection. A summary of the chromatographic setup conditions for validation and analysis are represented in Table 2 . 
Analytical Method Validation
Calibration curves were obtained by plotting the PN ratios versus concentrations after the analysis of the injected samples ( Figure 2 ).
Figure 2. Linearity equation of OLO.
The linearity of the method was established in the 5-50 µg/mL OLO range and showed excellent correlation within the concentration range. Regression statistics data of the six individual replicates were summarized in Table 3 . The coefficient of determination close to unity was not the necessarily outcome of a linear relationship and the use of only this value could be potentially misleading according to the Analytical Methods Committee (AMC) technical brief 17 . Therefore, the lack-of-fit test was applied as an auxiliary indicator for linearity by evaluating the variance of the residual values (Table 4) ance (ANOVA) results were calculated by Minitab ® 18 data analysis sofware and confirmed linearity significance of the curve, homogeneity of variances, and normality of the residues. The lack-of-fit was not statistically significant as P-value > 0.05 (0.754) which means the test did not detect any lack-of-fit at the α level in the simple linear regression model. The accuracy of the method was determined by recovery studies of the known contentrations. Analysis was carried out by the proposed method. The percentage recovery data were found to be accurate and in the acceptance limit of ±2%. The results indicated a low variability and a strong agreement between the theoretical known amount and calculated assay amount. The percentage recovery data, difference between mean and accepted true values and confidence intervals were presented in Table 5 . The precision study was performed on three concentration levels (low, medium, and high) to evaluate the repeatability and intermediate precision of the analytical method. Analyses were carried out on three consecutive days to show the intra-day and inter-day variations. The precision of the method was verified and found to be within the targeted intervals since the RSD is below 2%. The precision data were presented in Table 6 . The inter-day results of the three days were pooled and analyzed by GraphPad Prism 7 software. The specificity of the developed method was conducted with OLO loaded and placebo formulations. It was determined that overlapping effect of other formulation components did not affect the OLO peak ( Figure 3 ). It was therefore concluded that the developed method was specific and the OLO peak was distinctly separated from other components in the formulations. The parameters LOD and LOQ were calculated using the standard deviation of y-axis interception values of the calibration curve and the slope of the calibration curve. The lowest OLO concentration detected and quantified were 0.7652 and 2.3188 µg/mL respectively. Calculated LOD and LOQ concentrations could be considered as relatively high. The possible reasons of this situation were the use of PDA detector or high content of organic solvent and partial UV-cutoff effect. Nevertheless, these results proved that the chromatographic method was suitable enough to detect and quantify OLO at a concentration range of 5 to 50.0 µg/mL.
The robustness of the developed method was investigated with slight changes in the column temperature, pH of the mobile phase and flow rate. However, these changes had an influence on the assay and stability, the method was considered robust as the RSD values were below 2% for the OLO content.
Determination of OLO in Polymeric Nanoparticles
The OLO content and encapsulation efficiency of the polymeric nanoparticles was carried out by the validated UPLC method. The results of characterizations and 6 months stability of the formulations (25°C and 60% RH) were presented in Table 7 . The entrapment efficiency was evaluated according to Equation 4 . Superficial and free OLO content was found higher than the encapsulated for both NP1 and NP2 formulations. Drug and polymer concentration ratios was found to be a significant factor for the entrapment efficiency 18 . Although the amount of OLO in the NP2 formulation was greater than NP1, NP2 was less loaded. As a result of the stability studies over 6 months, no statistically significant change was observed (p>0.05) in OLO T , OLOS and the entrapment efficiency. 
CONCLUSION
Analytical method validation was performed to confirm that the analytical procedure developed was adequate for its intended use, and that the results derived could be utilized to determine the reliability and consistency of the analytical data obtained. The method was completely validated for linearity, accuracy, precision, specificity, LOD, LOQ and robustness according to the ICH harmonised tripartite guideline "validation of analytical procedures Q2(R1)" and showed satisfactory data for all tested parameters. As a result, this method particularly exhibited an excellent sensitivity and speed performance for the determination of OLO.
This newly developed UPLC method was also successfully applied for the determination of OLO in polymeric nanoparticle formulations, encapsulation efficiency and the stability studies. The results were found within higher confidence. In conclusion, this stability indicating method can be used and adaptable for the determination of OLO in similar pharmaceutical dosage forms.
